Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled time : 00:20 save search
CEREVEL THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cerevel Therapeutics - CERE
Published: 2024-01-26 (Crawled : 00:20) - prnewswire.com
TGH | $49.99 0.0% 1.2M
|
Finance
| Email alert
Add to watchlist
ABBV | News | $165.09 0.26% 760K
|
Health Technology
| Email alert
Add to watchlist
alert therapeutics
FREELINE THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Freeline Therapeutics Holdings plc - FRLN
Published: 2024-01-26 (Crawled : 00:20) - prnewswire.com
PWFL | $3.995 -1.6% 10K
|
Electronic Technology
| Email alert
Add to watchlist
FRLN | $6.48 0.0% 0
|
Health Technology
| Email alert
Add to watchlist
alert therapeutics
BCLI FINAL DEADLINE TUESDAY: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses in Excess of $500K to Secure Counsel Before Important January 2 Deadline in Securities Class Action Filed by the Firm - BCLI
Published: 2023-12-30 (Crawled : 00:20) - prnewswire.com
ON | $62.37 -0.89% 1.1M
|
Electronic Technology
| Email alert
Add to watchlist
BCLI | $0.5143 36K
|
Health Technology
| Email alert
Add to watchlist
MIST | $1.63 2.6K
|
Health Technology
| Email alert
Add to watchlist
deadline cell global therapeutics
BCLI LOSS ALERT: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation - BCLI
Published: 2023-09-29 (Crawled : 00:20) - prnewswire.com
AVAV 4 | $148.605 1.3% 35K
|
Electronic Technology
| Email alert
Add to watchlist
BCLI | $0.5143 36K
|
Health Technology
| Email alert
Add to watchlist
cell global therapeutics
Zevra Therapeutics Presents Full Data Set on the Cardiovascular Safety and Pharmacokinetics of SDX, the sole API in KP1077, in Healthy Volunteers at Psych Congress 2023
Published: 2023-09-10 (Crawled : 00:20) - globenewswire.com
ZVRA | $4.6 2.22% 40K
|
n/a
| Email alert
Add to watchlist
kp1077 congress set therapeutics cardiovascular
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 7, 2023
Published: 2023-04-07 (Crawled : 00:20) - biospace.com/
FULC | $7.2 1.98% 40K
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants therapeutics
Chinook Therapeutics Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - April 7, 2023
Published: 2023-04-07 (Crawled : 00:20) - biospace.com/
KDNY | $40.39 0.22% -0.17% 0
|
Health Technology
| Email alert
Add to watchlist
nasdaq grant therapeutics
Mersana Therapeutics Provides Statement About SVB
Published: 2023-03-11 (Crawled : 00:20) - globenewswire.com
MRSN | $3.285 -1.65% 120K
|
Health Technology
| Email alert
Add to watchlist
therapeutics
Mineralys Therapeutics Presents Positive Lorundrostat Results from the Phase 2 Target-HTN Trial at ACC.23/WCC
Published: 2023-03-04 (Crawled : 00:20) - globenewswire.com
MLYS M | $11.03 2.61% 12K
|
| Email alert
Add to watchlist
trial therapeutics positive results phase 2
Worldwide Osteoarthritis Therapeutics Industry to 2029 - Increased Use of Pain Relievers and Growing Frequency of Osteoarthritis Drives Growth
Published: 2023-02-10 (Crawled : 00:20) - prnewswire.com
PFE A | $25.44 0.2% 4.4M
|
Health Technology
| Email alert
Add to watchlist
GSK | $39.565 0.75% 170K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 600K
|
Health Technology
| Email alert
Add to watchlist
NVS | $93.43 0.93% 220K
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.145 1.78% 1.3M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.135 1.64% 270K
|
Health Technology
| Email alert
Add to watchlist
ZBH | $119.66 0.28% 140K
|
Health Technology
| Email alert
Add to watchlist
GLAXF | $20.2 0.65% 0
|
Health Technology
| Email alert
Add to watchlist
osteoarthritis growing therapeutics growth
Alzheimer's Disease Therapeutics Market Report Research 2022: Increasing Gap of Unmet Need of Effective Therapeutics
Published: 2023-01-20 (Crawled : 00:20) - prnewswire.com
DNLI | $16.74 0.84% 62K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $146.315 0.4% 1.3M
|
Health Technology
| Email alert
Add to watchlist
research disease report alzheimer's therapeutics market
Global Messenger RNA (mRNA) Vaccines & Therapeutics Markets, 2022-2023 & 2028: Rising Demand for Therapeutic Drugs and Vaccines for Ebola, influenza, HIV, and Other Viral Illnesses
Published: 2023-01-06 (Crawled : 00:20) - prnewswire.com
CVAC | News | $2.44 35K
|
Health Technology
| Email alert
Add to watchlist
global therapeutics vaccine hiv
Intellia Therapeutics Presents New Interim Data from First-in-Human Study of NTLA-2002 for the Treatment of Hereditary Angioedema (HAE) at the American College of Allergy, Asthma & Immunology 2022 Annual Scientific Meeting
Published: 2022-11-12 (Crawled : 00:20) - globenewswire.com
NTLA | $21.54 1.03% 85K
|
Health Technology
| Email alert
Add to watchlist
ntla-2002 treatment immunology meeting therapeutics study hereditary angioedema
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-11-11 (Crawled : 00:20) - globenewswire.com
FULC | $7.2 1.98% 40K
|
Health Technology
| Email alert
Add to watchlist
therapeutics nasdaq grants
Vera Therapeutics Presents New Analysis of Phase 2a JANUS Trial of Atacicept in IgA Nephropathy and Positive Final Phase 2 Results of MAU868 in Kidney Transplant Recipients with Reactivated BK Virus Infection at the American Society of Nephrology Kidney Week 2022 Annual Meeting
Published: 2022-11-05 (Crawled : 00:20) - globenewswire.com
VERA | $39.715 0.6% 110K
|
Professional, Scientific, and T...
| Email alert
Add to watchlist
mau868 nephropathy meeting kidney virus week trial therapeutics positive results infection phase 2b
Calidi Biotherapeutics Announces Appointment of Alfonso "Chito" Zulueta, Former President of International for Eli Lilly, to Its Board of Directors
Published: 2022-02-04 (Crawled : 00:20) - biospace.com/
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -2.52%
H: 0.0%
C: 0.0%
CTS S | $43.435 0.78% 11K
|
Electronic Technology
|
| O: -1.38%
H: 0.0%
C: 0.0%
ces therapeutics iot
Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Revance Therapeutics, Inc. (RVNC) That a Securities Fraud Class Action Lawsuit Has Been Filed On Their Behalf
Published: 2022-02-04 (Crawled : 00:20) - prnewswire.com
RVNC | $3.81 0.53% 140K
|
Health Technology
| Email alert
Add to watchlist
therapeutics deadline
iTeos Therapeutics Set to Join S&P SmallCap 600
Published: 2021-12-31 (Crawled : 00:20) - prnewswire.com
SPGI | News | $413.55 0.04% 110K
|
Commercial Services
| Email alert
Add to watchlist
CNC | $74.025 0.37% 260K
|
Health Services
| Email alert
Add to watchlist
therapeutics set
RVNC DEADLINE REMINDER: Kessler Topaz Meltzer & Check, LLP - Important LP February 8, 2022 Deadline Reminder for Revance Therapeutics, Inc.
Published: 2021-12-25 (Crawled : 00:20) - prnewswire.com
RVNC | $3.81 0.53% 140K
|
Health Technology
| Email alert
Add to watchlist
therapeutics deadline
Gainers vs Losers
| 82% | 18% |
Top 10 Gainers
AGBA | News | $1.37 242.5% 76M
|
Finance
EGOX | $0.0835 131.94% 160M
|
ZCMD | $2.18 50.35% 24M
|
Commercial Services
CHRO | $1.73 41.22% 46K
|
n/a
RWOD | $10.61 32.68% 5.1M
|
n/a
NVFY | $2.77 31.28% 2.2M
|
Consumer Durables
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
Your saved searches
Save your searches and get alerts when important news are released.